HIV and tuberculosis in India

Journal of Biosciences

Volumn 33, Issue 4, 2008, Pages 527-537

  Swaminathan, Soumya ^a   Narendran, G ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

Author keywords

Clinical features; Control program; HIV; India; Tuberculosis

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; CYCLOSERINE; DELAVARIDINE; DIDANOSINE; EFAVIRENZ; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; OFLOXACIN; PROTEINASE INHIBITOR; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; STREPTOMYCIN; TENOFOVIR; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DISEASE CONTROL; DISEASE INCIDENCE; DISEASE TREATMENT; DRUG RESISTANCE; EPIDEMIC; HUMAN IMMUNODEFICIENCY VIRUS; INFECTIOUS DISEASE; MORTALITY; PUBLIC HEALTH; TOXICITY; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIZZINESS; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG RESISTANCE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; EXTRAPULMONARY TUBERCULOSIS; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERURICEMIA; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOSUPPRESSIVE TREATMENT; INDIA; INFECTION RISK; LIVER TOXICITY; LUNG TUBERCULOSIS; MENTAL DISEASE; MIXED INFECTION; MULTIDRUG RESISTANT TUBERCULOSIS; NEPHROTOXICITY; NEUROPATHY; NONHUMAN; OPPORTUNISTIC INFECTION; PARESTHESIA; PATIENT COMPLIANCE; PERIPHERAL NEUROPATHY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SENSITIVITY AND SPECIFICITY; SLEEP DISORDER; TUBERCULOSIS;

ANTI-HIV AGENTS; ANTIBIOTICS, ANTITUBERCULAR; DISEASE OUTBREAKS; DRUG INTERACTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HIV INFECTIONS; HUMANS; INCIDENCE; INDIA; MASS SCREENING; PREVALENCE; TUBERCULOSIS;

ASIA; EURASIA; INDIA; SOUTH ASIA;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 58149145610     PISSN: 02505991     EISSN: 02505991     Source Type: Journal    
DOI: 10.1007/s12038-008-0071-2     Document Type: Review

References (61)

1. A. N. Ackah D. Coulibaly H. Digbeu K. Diallo K. M. Vetter I. M. Coulibaly A. E. Greenberg K. M. De Cock 1995 Response to treatment, mortality and CD4 lymphocyte counts in HIV infected persons with tuberculosis in Abidjan, Cote d'Ivoire Lancet 345 607 610
2. Agarwal S P and Chauhan L S 2005 Tuberculosis control in India (Elsevier, a division of Reed Elsevier India Private Limited)
3. Z. Ahmad M. Shameem 2005 Manifestations of Tuberculosis in HIV Infected Patients JIACM 6 302 305
4. J. R. Andrews N. S. Shah N. Gandhi T. Moll G. Friedland Tugela Ferry CareResearch 2007 Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa J. Infect. Dis. 196 Suppl.3 S482 S490
5. G. Antonucci E. Girardi M. C. Raviglione G. Ippolito 1995 Risk factors for tuberculosis in HIV-infected persons: A prospective cohort study JAMA 274 143 148
6. V. K. Arora S. V. Kumar 1999 Pattern of opportunistic pulmonary infections in HIV sero-positive subjects: observations from Pondicherry, India Indian J. Chest Dis. Allied Sci. 41 135 144
7. W. J. Burman B. E. Jones 2001 Treatment of HIV-related Tuberculosis in the Era of Effective Antiretroviral Therapy Am. J. Respir. Crit. Care Med. 164 7 12
8. K. Cohen G. van Cutsem A. Boulle H. McIlleron E. Goemaere P. J. Smith G. Maartens 2008 Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis J. Antimicrob. Chemother. 61 389 393
9. K. M. De Cock B. Soro I. M. Coulibaly S. B. Lucas 1992 Tuberculosis and HIV infection in sub-Saharan Africa JAMA 268 1581 1587
10. B. C. de Jong D. M. Israelski E. L. Corbett P. M. Small 2004 Clinical management of tuberculosis in the context of HIV infection Annu. Rev. Med. 55 283 301
11. C. N. Deivanayagam S. Rajasekaran V. Senthilnathan R. Krishnarajasekhar K. Raja C. Chandrasekar S. Palanisamy A. Samuel Dinesh G. Jothivel S. V. Elango 2001 Clinicoradiological spectrum of tuberculosis among HIV sero-positives - a Tambaram study Indian J. Tuber. 48 123 127
12. C. R. Driver S. S. Munsiff J. Li N. Kundamal S. S. Osahan 2001 Relapse in persons treated for drug susceptible tuberculosis in a population with high co-infection with Human Immunodeficiency virus in New York City Clin. Infect. Dis. 33 1762 1769
13. Emergence of XDR-TB WHO concern over extensive drug resistant TB strains that are virtually untreatable 2006; accessed from http://www.who.int/ mediacentre/news/notes/2006/np23/en/print.html on 25/05/08
14. M. J. Fee M. M. Oo A. E. Gabayan D. R. Radin P. F. Barnes 1995 Abdominal tuberculosis in patients infected with the human immunodeficiency virus Clin. Infect. Dis. 20 938 944
15. Finlay A F, Walt M V, Holtz T H, Thorpe L E, Wells C D and Weyer K 2004 Treatment outcome of patients with multidrug resistant tuberculosis in south Africa using a standardized regimen, 1999-2000 (abstract 584); in Program and abstracts of the infectious diseases (Society of America 2004 Annual Meeting Alexandria, VA: infectious Disease society of America) p. 155
16. A. Gil-Setas L. Torroba J. L. Fernandez V. Martinez-Artola J. Olite 2004 Evaluation of the MB/BacT system compared with Middlebrook 7H11 and Lowenstein-Jensen media for detection and recovery of mycobacteria from clinical specimens Clin. Microbiol. Infect. 10 224 228
17. A. D. Harries N. J. Hargreaves A. Jindani D. A. Enarson D. Meher F. M. Salaniponi 2001 Deaths from tuberculosis in Sub-Saharan African countries with a high prevalence of HIV -1 Lancet 357 1519 1523
18. D. V. Havlir P. F. Barnes 1999 Tuberculosis in patients with human immunodeficiency virus infection N. Engl. J. Med. 340 367 373
19. A. Jindani A. J. Nunn D. A. Enarson 2004 Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomized trial Lancet 364 1244 1251
20. D. Kejariwal N. Sarkar S. K. Chakraborti V. Agarwal S. Roy 2001 Pyrexia of unknown origin: a prospective study of 100 cases J. Postgrad. Med. 47 104 107
21. N. Kumarasamy S. Vallabhaneni T. P. Flanigan K. H. Mayer S. Solomon 2005 Clinical profile of HIV in India Indian J. Med. Res. 121 377 394
22. S. D. Lawn L. G. Bekker R. F. Miller 2005 Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals Lancet Infect. Dis. 5 361 373
23. S. D. Lawn S. B. Butera T. M. Shinnick 2002 Tuberculosis unleashed: the impact of HIV infection on the host granulomatous response to mycobacterium tuberculosis Microbes Infection 4 635 646
24. S. D. Lawn L. Myer L. G. Bekker R. Wood 2007 Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa AIDS 21 335 341
25. Lawn S, Myer L, Bekker L G and Wood R 2007 Early mortality among patients with HIV associated TB in Africa: Implications for the time to initiate ART (Conference on Retroviruses and Opportunistic Infections: Abstract 81)
26. J. J. Lee J. Suo C. B. Lin J. D. Wang T. Y. Lin Y. C. Tsai 2003 Comparative evaluation of the BACTEC MGIT 960 system with solid medium for isolation of mycobacteria Int. J. Tuber. Lung Dis. 7 569 574
27. R. Long B. Maycher M. Scalcini J. Manfred 1991 Chest roentgenogram in pulmonary tuberculosis patients seropositive for HIV type I Chest 99 123 127
28. S. B. Lucas K. M. De Cock A. Hounnou C. Peacock M. Diomande M. Hondé A. Beaumel L. Kestens A. Kadio 1994 Contribution of tuberculosis to slim disease in Africa BMJ 308 1531 1533
29. Y. C. Manabe J. D. Campbell E. Sydnor R. D. Moore 2007 Immune reconstitution inflammatory syndrome: risk factors and treatment implications J. Acquir. Immune Defici. Syndr. 46 456 462
30. W. Manosuthi W. Mankatitham A. Lueangniyomkul S. Chimsuntorn S. Sungkanuparph 2008 Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin HIV Med. 9 294 299
31. W. Manosuthi S. Sungkanuparph A. Thakkinstian S. Rattanasiri A. Chaovavanich W. Prasithsirikul S. Likanonsakul K. Ruxrungtham 2006 Plasma nevirapine levels and 24-week efficacy in HIV-infected patients receiving nevirapine-based highly active antiretroviral therapy with or without rifampicin Clin. Infect. Dis. 43 253 255
32. H. McIlleron G. Meintjes W. J. Burman G. Maartens 2007 Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome J. Infect. Dis. (Suppl. 1) 196 S63 S75
33. A. Miranda M. Morgan L. Jamal K. Laserson D. Barreira G. Silva J. Santos C. Wells P. Paine D. Garrett 2007 Impact of antiretroviral therapy on the incidence of tuber-culosis: the Brazilian experience, 1995-2001 PLoS ONE 2 e826
34. A. Mohammed L. Myre R. Ehrlich R. Wood F. Cilliers G. Maartens 2007 Randomised controlled trial of isoniazid preventive therapy in South African adults with advanced HIV disease Int. J. Tuber. Lung Dis. 11 1114 1120
35. P. Nahid L. C. Gonzalez I. Rudoy B. C. De long A. Unger L. M. Kawamura 2007 Treatment outcomes of patients with HIV and tuberculosis Am. J. Respire. Crit. Care Med. 175 1196 1206
36. M. Narita D. Ashkin E. S. Hollender A. E. Pitchenik 1998 Paradoxical worsening of tuberculosis following Antiretroviral therapy in patients with AIDS Am. Crit. Care 158 157 161
37. M. Narita M. Kellman D. L. Franchini M. E. McMillan E. S. Hollender D. Ashkin 2002 Short course rifampicin and pyrazinamide treatment for latent tuberculosis infection in patients with HIV infection: the 2 year experience of a comprehensive community based programme in Broward county, Florida Chest 122 1292 1298
38. National AIDS Control Organization 2007 Antiretroviral therapy guidelines for HIV-infected adults and adolescents including post-exposure prophylaxis (Section A7)
39. M. M. Park A. L. Davis N. W. Schluger H. Cohen W. N. Rom 1996 Outcome of MDR -TB patients, 1983-1993: prolonged survival with appropriate therapy Am. J. Respir. Crit. Care Med. 153 317 324
40. R. Ramachandran S. Swaminathan S. Somasundaram V. N. Asgar P. Paramesh C. N. Paramasivan 2002 Mycobacteremia in tuberculosis patients with HIV infection Indian J. Tuberc. 50 29 31
41. Rieder H L 1999 Epidemiological basis of tuberculosis control First edition [International Union against Tuberculosis and Lung Diseases (UNION)] pp 50-52
42. P. Rupali O. C. Abraham A. Zachariah S. Subramanian D. Mathai 2003 Aetiology of prolonged fever in antiretroviral-naïve human immunodeficiency virus-infected adults Natl. Med. J. India 16 193 199
43. S. A. Sahn T. A. Neff 1974 Miliary tuberculosis Am. J. Med. 56 494 505
44. S. K. Sharma A. Mohan T. Kadhiravan 2005 HIV-TB co-infection: epidemiology, diagnosis & management Indian J. Med. Res. 121 550 567
45. S. Singh K. Gopinath S. Shahdad M. Kaur B. Singh P. Sharma 2007 Nontuberculous mycobacterial infections in Indian AIDS patients detected by a novel set of ESAT-6 polymerase chain reaction primers Jpn. J. Infect. Dis. 60 14 18
46. S. Singh M. M. Sankar K. Gopinath 2007 High rate of extensively drug-resistant tuberculosis in Indian AIDS patients AIDS 21 2345 2347
47. K. R. Steingart M. Henry V. Ng P. C. Hopewell A. Ramsay J. Cunningham R. Urbanczik M. Perkins M. A. Aziz M. Pai 2006 Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review Lancet Infect. Dis. 6 570 581
48. S. Swaminathan C. N. Deivanayagam S. Rajasekaran P. Venkatesan C. Padmapriyadarsini P. A. Menon C. Ponnuraja M. Dilip 2008 Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy Natl. Med. J. Indian 21 3 7
49. S. Swaminathan G. Narendran P. A. Menon C. Padmapriyadarsini N. Arunkumar N. M. Sudharshanam S. Ramesh Kumar S. Chandrasekhar 2007 Impact of HIV infection on radiographic features in patients with pulmonary tuberculosis Indian J. Chest Dis. Allied Sci. 49 133 136
50. S. Swaminathan C. N. Paramasivan C. Ponnuraja S. Iliayas S. Rajasekaran P. R. Narayanan 2005 Anti-tuberculosis drug resistance tuberculosis in South India Int. J. Tuberc. Lung Dis. 9 896 900
51. S. Swaminathan R. Ramachandran G. Baskaran C. N. Paramasivan U. Ramanathan P. Venkatesan R. Prabhakar M. Datta 2000 Risk of development of tuberculosis in HIV infected patients Int. J. Tuberc. Lung Dis. 4 839 844
52. S. Swaminathan R. Subbaraman P. Venkatesan S. Subramanyam S. Ramesh Kumar K. H. Mayer P. R. Narayanan 2008 Tuberculin skin test results in HIV-infected patients in India: Implications for latent tuberculosis treatment Int. J. Tuberc. Lung Dis. 12 168 173
53. TB/HIV, A Clinical Manual, WHO 2004 accessed from http://libdoc.who.int/ publications/2004/9241546344.pdf on 25/05/2008
54. A. Thomas R. Ramachandran F. Rehaman K. Jaggarajamma T. Santha N. Selvakumar N. Krishnan N. S. Mohan V. Sundaram F. Wares P.R. Narayanan 2007 Management of multi drug resistance tuberculosis in the field: Tuberculosis Research Centre experience Indian J. Tuberc. 54 117 124
55. B. E. Thomas R. Ramachandran S. Anitha S. Swaminathan 2007 Feasibility of routine HIV testing among TB patients through a Voluntary, Counseling and Testing Centre (VCTC) Int. J. Tuberc. Lung Dis. 11 1296 1301
56. WHO Smear Negative Algorithm 2006 Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents; Accessed from http://www.who.int/tb/publications/2006/ tbhiv_recommendations.pdf
57. William R and Stuart G 2004 Tuberculosis (New York: Lippin Cott Williams and Wilkins)
58. N. Williams-Bouyer R. Yorke H. I. Lee G. L. Woods 2000 Comparison of the BACTEC MGIT 960 and ESP culture system II for growth and detection of mycobacteria J. Clin. Microbiol. 38 4167 4170
59. Woldehanna S and Volmink J 2004 Treatment of latent tuberculosis infection in HIV infected persons; Cochrane Database Syst. Rev. 1 CD000171
60. World Health Organization 2006 Initiating First-Line ART in Relationship to Starting Anti-TB Therapy; accessed from http://www.womenchildrenhiv.org/ wchiv?page=charts-00-13 on 25/05/2008
61. World Health Organization 2008. Global tuberculosis control: surveillance, planning, financing. WHO report 2008. WHO/HTM/TB/2008.393. Geneva